Midterm echocardiographic follow-up of cardiac function after living kidney donation

Bernd Hewing1, Henryk Dreger, Fabian Knebel

  • 1Medizinische Klinik mit Schwerpunkt Kardiologie und Angiologie, and Medizinische Klinik für Nephrologie, Charité-Universitätsmedizin Berlin, Campus Mitte, Berlin, Germany.

Clinical Nephrology
|April 23, 2015
PubMed

Insights

Living kidney donation (LKD) shows no immediate negative impact on donor heart function, despite increased blood pressure and creatinine levels. Further research is needed to confirm long-term safety for kidney donors.

Area of Science:

  • Nephrology
  • Cardiology
  • Transplantation

Background:

  • Living kidney donation (LKD) is crucial for end-stage renal disease patients.
  • Concerns exist regarding potential increased cardiovascular mortality post-LKD.
  • Donor safety is paramount in kidney donation procedures.

Purpose of the Study:

  • To evaluate cardiac structure and function changes after LKD.
  • To assess the short-term cardiovascular impact on living kidney donors.
  • To utilize advanced echocardiographic methods for precise measurements.

Main Methods:

  • 30 living kidney donors underwent medical exams, lab tests, and echocardiography pre- and post-donation.
  • Standard echocardiographic indices assessed left ventricular (LV) and right ventricular (RV) function.
  • 2D speckle tracking analyzed LV and left atrial (LA) longitudinal strain.

Main Results:

  • Serum creatinine significantly increased post-LKD (0.80 to 1.18 mg/dL).
  • A trend towards higher blood pressure and increased antihypertensive drug use was observed.
  • No significant changes in LV, LA, or RV function parameters were detected by echocardiography.
  • N-terminal pro-brain natriuretic peptide (NT-proBNP) levels remained normal.

Conclusions:

  • Elevated creatinine and blood pressure suggest potential long-term cardiac risk for kidney donors.
  • This pilot study found no evidence of short-term detrimental effects on cardiac structure or function after LKD.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
765
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
595
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
851
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.6K